Epila Hair Laser Removal System

 

 

 

 

 

 

 

 

 

 


 

Epila Hair Laser Removal System

 
Mall Offers Cosmetic Quick Fix

DALLAS -- A team of cosmetic surgeons is giving Botox and Restalyne shots in the oddest place. Forget the doctor's office, many North Texas women are coming to the mall for Botox and Restalyne, to a place called Klinger.

Klinger is a spa, salon and "cosmedical" center all in one. The store teams with plastic surgeons from UT Southwestern Medical Center to provide safe, yet speedy light medical procedures.

The war on wrinkles can be rigorous, not to mention pricey, but most women, like Stacy Merritt of Dallas, are in for the wrangling. .


Syneron wins $6m order from American Laser Centers

Aesthetic surgical devices maker Syneron Medical Ltd. (Nasdaq: ELOS) is expanding its collaboration with US clinics chain American Laser Centers. Exactly 11 months after Syneron announced that it would supply the chain with its VelaSmooth and Aurora products, it has received has received an order from the company worth an initial $6 million.

Syneron will supply American Laser Centers with devices from its eLine product line, considered one of the companys growth engines. Syneron currently has three products in this line: eLight is a treatment for acne, superficial benign vascular and pigmented lesions: eLaser removes hair and treats vascular veins; and eMax is a work station for the companys electro-optical synergy (ELOS) technology.

Under the present contract, Syneron will deliver its eLaser and eLight products to 120 American Laser Centers clinics across the US.


Cutera Takes 2Q Loss on Legal Charge

Cutera Inc., which makes laser skin treatments used by dermatologists and plastic surgeons, on Monday said it swung to a second-quarter loss, weighed down by $22 million patent settlement with rival Palomar Medical Technologies.

The company posted a loss of $9 million, or 73 cents per share, compared with a profit of $2.7 million, or 20 cents per share, a year ago. Cutera anticipated the loss in June and lowered its guidance to a loss of 89 cents per share from a 12-cent gain.

Excluding the legal charge and stock option expenses, the company said it earned 20 cents per share.

Analysts polled by Thomson Financial expected, on average, earnings of 9 cents per share.

Revenue jumped 38.8 percent to $24.4 million from $17.6 million. Analysts expected revenue of $22.8 million.


Link to us - Partners & Resources - Contact us